Compare NGNE & ASC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | ASC |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.9M | 751.7M |
| IPO Year | 2014 | 2013 |
| Metric | NGNE | ASC |
|---|---|---|
| Price | $23.57 | $19.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $77.88 | $22.50 |
| AVG Volume (30 Days) | 354.4K | ★ 643.7K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.63% |
| EPS Growth | ★ 0.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.93 | $10.31 |
| 52 Week High | $43.66 | $20.60 |
| Indicator | NGNE | ASC |
|---|---|---|
| Relative Strength Index (RSI) | 33.88 | 52.63 |
| Support Level | $16.88 | $18.25 |
| Resistance Level | $29.16 | $19.14 |
| Average True Range (ATR) | 1.99 | 0.72 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 29.31 | 40.77 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.